Literature DB >> 2164419

Heparan sulfate proteoglycan from human tubular basement membrane. Comparison with this component from the glomerular basement membrane.

L P van den Heuvel1, J van den Born, J H Veerkamp, T J van de Velden, L Schenkels, L A Monnens, C H Schröder, J H Berden.   

Abstract

Heparan sulfate proteoglycan (HSPG) was extracted from human tubular basement membrane (TBM) with guanidine and purified by ion-exchange chromatography and gel filtration. The glycoconjugate was sensitive to heparitinase and resistant to chondroitinase ABC, had an apparent molecular mass of 200-400 kDa and consisted of 70% protein and 30% glycosaminoglycan. The amino acid composition was characterized by its high content of glycine, proline, alanine and glutamic acid. Hydrolysis with trifluoromethanesulfonic acid yielded core proteins of 160 and 110 kDa. The heparan sulfate (HS) chains obtained after alkaline NaBH4 treatment had a molecular mass of about 18 kDa. Results of heparitinase digestion and HNO2 treatment suggest a clustering of sulfate groups in the distal portion of the HS side chains. These chemical data are comparable to those obtained previously on glomerular basement membrane (GBM) HSPG (Van den Heuvel et al. (1989) Biochem. J. 264, 457-465). Peptide patterns obtained after trypsin, clostripain or V8 protease digestion of TBM and GBM HSPG preparations showed a large similarity. Polyclonal antisera and a panel of monoclonal antibodies raised against both HSPG preparations and directed against the core protein showed complete cross-reactivity in ELISA and on Western blots. They stained all basement membranes in an intense linear fashion in indirect immunofluorescence studies on human kidneys. Based on these biochemical and immunological data we conclude that HSPGs from human GBM and TBM are identical, or at least very closely related, proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164419     DOI: 10.1016/0005-2736(90)90191-p

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and intracellular Ca2+.

Authors:  Shizuka Iida; Masaru Ishimatsu; Shyumei Chikama; Michiro Inoue; Kei Matsuoka; Takashi Akasu; Shinshi Noda; Saeed R Khan
Journal:  Urol Res       Date:  2003-04-29

Review 2.  Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.

Authors:  Albert S B Edge
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

3.  The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type.

Authors:  L P Van den Heuvel; J Van den Born; H Jalanko; C H Schröder; J H Veerkamp; K J Assmann; J H Berden; C Holmberg; J Rapola; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

4.  Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid.

Authors:  J H Magnus; T Stenstad; G Husby; S O Kolset
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  Interplay between transglutaminases and heparan sulphate in progressive renal scarring.

Authors:  Izhar Burhan; Giulia Furini; Hugues Lortat-Jacob; Adeola G Atobatele; Alessandra Scarpellini; Nina Schroeder; John Atkinson; Mabrouka Maamra; Faith H Nutter; Philip Watson; Manlio Vinciguerra; Timothy S Johnson; Elisabetta A M Verderio
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.